Search Results - "Chao-hung Hung"

How organizational green culture influences green performance and competitive advantage: The mediating role of green innovation by Wang, Chao-Hung

“…PurposeGrowing public concern about the natural environment is rapidly transforming the competitive landscape and forcing firms to adopt green innovation…”
Get full text

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir by Kuo, Ming‐Te, Hu, Tsung‐Hui, Hung, Chao‐Hung, Wang, Jing‐Houng, Lu, Sheng‐Nan, Tsai, Kai‐Lung, Chen, Chien‐Hung

“…Summary Background Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are first‐line long‐term monotherapy for treatment of chronic hepatitis B (CHB)…”
Get full text

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B by Chen, Chien‐Hung, Peng, Cheng‐Yuan, Hu, Tsung‐Hui, Wang, Jing‐Houng, Hung, Chao‐Hung, Lu, Sheng‐Nan

“…Summary Background/Aims To compare the rates of hepatitis B surface antigen (HBsAg) loss after discontinuation of entecavir versus tenofovir disoproxil…”
Get full text

Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non‐alcoholic fatty liver disease by Wang, Jing‐Houng, Ou, Hsin‐You, Yen, Yi‐Hao, Hung, Chao‐Hung, Lu, Sheng‐Nan

“…Background and Aims Magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) is the reference standard of hepatic steatosis assessment. This…”
Get full text

Dinuclear Metal‐ProPhenol Catalysts: Development and Synthetic Applications by Trost, Barry M., Hung, Chao‐I (Joey), Mata, Guillaume

“…The ProPhenol ligand is a member of the chiral aza‐crown family that spontaneously forms a bimetallic complex upon treatment with alkyl metal reagents, such as…”
Get full text

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients by Huang, Pao‐Yuan, Wang, Jing‐Houng, Hung, Chao‐Hung, Lu, Sheng‐Nan, Hu, Tsung‐Hui, Chen, Chien‐Hung

“…This study investigated the ability of hepatitis B core‐related antigen (HBcrAg) to predict hepatitis B virus (HBV) relapse in HBeAg‐negative patients after…”
Get full text

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use by Kuo, Yuan‐Hung, Wang, Jing‐Houng, Hung, Chao‐Hung, Rau, Kun‐Ming, Wu, I‐Pei, Chen, Chien‐Hung, Kee, Kwong‐Ming, Hu, Tsung‐Hui, Lu, Sheng‐Nan

“…Background and Aim The Albumin‐Bilirubin (ALBI) grade is a new index to assess objectively liver function and prognosis in patients with hepatocellular…”
Get full text

Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma by Wang, Jing-Houng, Wang, Chih-Chi, Hung, Chao-Hung, Chen, Chao-Long, Lu, Sheng-Nan

“…Background & Aims To compare the survival between surgical resection (SR) and radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC) in…”
Get full text

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus by Hung, Chao‐Hung, Hu, Tsung‐Hui, Lu, Sheng‐Nan, Kuo, Fang‐Ying, Chen, Chien‐Hung, Wang, Jing‐Houng, Huang, Chao‐Min, Lee, Chuan‐Mo, Lin, Chih‐Yun, Yen, Yi‐Hao, Chiu, Yi‐Chun

“…Hepatocarcinogenesis is a multistep process that evolves from cirrhosis or dysplastic nodule (DN), and eventually leads to overt hepatocellular carcinoma…”
Get full text

An environmental perspective extends market orientation: Green innovation sustainability by Wang, Chao Hung

“…Though there has been much research into green performance, few studies have analyzed whether a green market orientation (GMO) is important. In this study, we…”
Get full text

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan by Hu, Tsung‐Hui, Yueh‐Hsia Chiu, Sherry, Tseng, Po‐Lin, Chen, Chien‐Hung, Lu, Sheng‐Nan, Wang, Jing‐Houng, Hung, Chao‐Hung, Kee, Kwong‐Ming, Lin, Ming‐Tsung, Chang, Kuo‐Chin, Lin, Meng‐Chih, Chien, Rong‐Nan

“…Summary Background Comparative long‐term efficacy of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) for prevention of disease progression to…”
Get full text

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment by Ma, Te-Ling, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Chen, Chien-Hung

“…This study investigated the incidence and predictors of retreatment after discontinuation of either entecavir (ETV) or tenofovir disoproxil fumarate (TDF)…”
Get full text

The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection by Lin, Chun-Yu, Lin, Chih-Che, Wang, Chih-Chi, Chen, Chao-Long, Hu, Tsung-Hui, Hung, Chao-Hung, Huang, Pao-Yuan, Tsai, Ming-Chao

“…Background Hepatocellular carcinoma (HCC) patients still have risk for very late recurrence after curative resection. This study assesses prognostic factors in…”
Get full text

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level by Yen, Yi-Hao, Kuo, Fang-Ying, Kee, Kwong-Ming, Chang, Kuo-Chin, Tsai, Ming-Chao, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Houng, Hung, Chao-Hung, Chen, Chien-Hung

“…The aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) are commonly used compound surrogates for advanced fibrosis in…”
Get full text

Low-dose nivolumab in advanced hepatocellular carcinoma by Chen, Yen-Hao, Wang, Chih-Chi, Chen, Yen-Yang, Wang, Jing-Houng, Hung, Chao-Hung, Kuo, Yuan-Hung

“…Background The approved dose of nivolumab is 3 mg/kg or a flat dose of 240 mg for indications. There is no dose-response relationship for nivolumab; therefore,…”
Get full text

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma by Chen, Yen-Hao, Tsai, Ching-Hua, Chen, Yen-Yang, Wang, Chih-Chi, Wang, Jing-Houng, Hung, Chao-Hung, Kuo, Yuan-Hung

“…Background Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety…”
Get full text

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals by Lee, Yu-Chi, Hu, Tsung-Hui, Hung, Chao-Hung, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng

“…Transient elastography and fibrosis-4 index (FIB-4) have been proposed to access hepatic fibrosis and steatosis for patients with chronic liver disease. This…”
Get full text

Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients by Chen, Yen-Hao, Chen, Yen-Yang, Wang, Jing-Houng, Hung, Chao-Hung

“…This study aimed to assess the clinical impact of lenvatinib after disease progression on atezolizumab plus bevacizumab in patients with advanced…”
Get more information

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients by Chen, Chien-Hung, Peng, Cheng-Yuan, Kuo, Yuan-Hung, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan

“…This study investigated the incidence and predictors of hepatitis B virus (HBV) relapse in patients with hepatitis B e antigen (HBeAg)-positive chronic…”
Get full text

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience by Tsai, Ming‐Chao, Lin, Chun‐Yen, Hung, Chao‐Hung, Lu, Sheng‐Nan, Tung, Shui‐Yi, Chien, Rong‐Nan, Lin, Chih‐Lang, Wang, Jing‐Houng, Chien‐Hung, Chen, Chang, Kuo‐Chin, Hu, Tsung‐Hui, Sheen, I‐Shyan

“…Renal toxicity of direct‐acting antivirals (DAAs) in chronic hepatitis C (CHC) patients has not been well‐characterized. The aim of this study was to assess…”
Get full text